NO20065657L - Filmformet ostriol-inneholdende medikament for oral administrasjon - Google Patents
Filmformet ostriol-inneholdende medikament for oral administrasjonInfo
- Publication number
- NO20065657L NO20065657L NO20065657A NO20065657A NO20065657L NO 20065657 L NO20065657 L NO 20065657L NO 20065657 A NO20065657 A NO 20065657A NO 20065657 A NO20065657 A NO 20065657A NO 20065657 L NO20065657 L NO 20065657L
- Authority
- NO
- Norway
- Prior art keywords
- film
- shaped
- ostriol
- oral administration
- containing drug
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 title abstract 2
- PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 abstract 2
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 abstract 2
- 229960001348 estriol Drugs 0.000 abstract 2
- WAHQVRCNDCHDIB-QZYSPNBYSA-N [(3s,8r,9s,10r,13s,14s,17r)-17-acetyl-17-acetyloxy-6,10,13-trimethyl-1,2,3,8,9,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-yl] 3-cyclopentylpropanoate Chemical compound O([C@@H]1C=C2C(C)=C[C@H]3[C@@H]4CC[C@]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)(OC(=O)C)C(C)=O)C(=O)CCC1CCCC1 WAHQVRCNDCHDIB-QZYSPNBYSA-N 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000000583 progesterone congener Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Physiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nutrition Science (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004023984A DE102004023984A1 (de) | 2004-05-14 | 2004-05-14 | Filmförmiges, oral zu verabreichendes Arzneimittel, enthaltend Estriol |
| PCT/EP2005/004894 WO2005110358A2 (de) | 2004-05-14 | 2005-05-06 | Filmförmiges, oral zu verabreichendes arzneimittel, enthaltend estriol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20065657L true NO20065657L (no) | 2006-12-07 |
Family
ID=34977101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20065657A NO20065657L (no) | 2004-05-14 | 2006-12-07 | Filmformet ostriol-inneholdende medikament for oral administrasjon |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20070243217A1 (pt) |
| EP (1) | EP1761242A2 (pt) |
| JP (1) | JP2007537178A (pt) |
| KR (1) | KR20070040753A (pt) |
| CN (1) | CN1997349A (pt) |
| AR (1) | AR048958A1 (pt) |
| AU (1) | AU2005244409A1 (pt) |
| BR (1) | BRPI0510855A (pt) |
| CA (1) | CA2566325A1 (pt) |
| DE (1) | DE102004023984A1 (pt) |
| IL (1) | IL179014A0 (pt) |
| MX (1) | MXPA06012890A (pt) |
| NO (1) | NO20065657L (pt) |
| RU (1) | RU2006140649A (pt) |
| TW (1) | TW200536547A (pt) |
| WO (1) | WO2005110358A2 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2252261A2 (en) * | 2008-02-13 | 2010-11-24 | Bayer Schering Pharma Aktiengesellschaft | Drug delivery system with stabilising effect |
| BRPI0908477A2 (pt) * | 2008-02-13 | 2018-03-27 | Bayer Schering Pharma Ag | sistema de distribuição de medicamento contendo estradiol |
| KR20110020782A (ko) * | 2008-04-24 | 2011-03-03 | 이브스트라, 인코포레이티드 | 장용 폴리머 중에 분산된 프로게스토겐 및 에스트로겐을 포함하는 경구 피임약 제형 |
| US20110250274A1 (en) * | 2008-09-19 | 2011-10-13 | Shaked Ze Ev | Estriol formulations |
| DE102009007771B4 (de) * | 2009-02-05 | 2012-02-16 | Bayer Schering Pharma Aktiengesellschaft | Bukkales Applikationssystem, 17α-Estradiol enthaltend |
| KR102044515B1 (ko) * | 2019-08-20 | 2019-11-14 | 이영환 | 구강점막 부착력이 우수한 서방형 구강붕해용 필름 및 이의 제조방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3888269T2 (de) * | 1987-09-24 | 1994-07-07 | Jencap Research Ltd | Hormon-Zusammensetzung und -Anwendung. |
| DE59309063D1 (de) * | 1992-03-21 | 1998-11-19 | Entec | Verwendung von östriol zur herstellung einen transdermalen therapeutischen systeme zur behandlung von klimakterischer osteoporose |
| DE19701949A1 (de) * | 1997-01-13 | 1998-07-16 | Jenapharm Gmbh | Transdermales therapeutisches System |
| DE19832169A1 (de) * | 1998-07-17 | 2000-01-27 | Jenapharm Gmbh | Lokal anwendbare pharmazeutische Präparate zur Prophylaxe und Therapie atrophischer Erscheinungen in der Mundhöhle |
| US6117446A (en) * | 1999-01-26 | 2000-09-12 | Place; Virgil A. | Drug dosage unit for buccal administration of steroidal active agents |
| DE19932603A1 (de) * | 1999-07-13 | 2001-01-25 | Gruenenthal Gmbh | Wirkstoffhaltiger Mehrschichtfilm aus in situ vernetzten hydrophilen Polymeren |
| KR100913910B1 (ko) * | 2000-01-18 | 2009-08-26 | 바이엘 쉐링 파마 악티엔게젤샤프트 | 호르몬 보충 요법용 드로스피렌온 |
-
2004
- 2004-05-14 DE DE102004023984A patent/DE102004023984A1/de not_active Ceased
-
2005
- 2005-05-04 TW TW094114391A patent/TW200536547A/zh unknown
- 2005-05-06 EP EP05747659A patent/EP1761242A2/de not_active Withdrawn
- 2005-05-06 CA CA002566325A patent/CA2566325A1/en not_active Abandoned
- 2005-05-06 AU AU2005244409A patent/AU2005244409A1/en not_active Abandoned
- 2005-05-06 US US11/596,239 patent/US20070243217A1/en not_active Abandoned
- 2005-05-06 CN CNA2005800140311A patent/CN1997349A/zh active Pending
- 2005-05-06 KR KR1020067023835A patent/KR20070040753A/ko not_active Withdrawn
- 2005-05-06 RU RU2006140649/15A patent/RU2006140649A/ru not_active Application Discontinuation
- 2005-05-06 WO PCT/EP2005/004894 patent/WO2005110358A2/de not_active Ceased
- 2005-05-06 MX MXPA06012890A patent/MXPA06012890A/es unknown
- 2005-05-06 JP JP2007512026A patent/JP2007537178A/ja active Pending
- 2005-05-06 BR BRPI0510855-1A patent/BRPI0510855A/pt not_active Application Discontinuation
- 2005-05-13 AR ARP050101957A patent/AR048958A1/es unknown
-
2006
- 2006-11-02 IL IL179014A patent/IL179014A0/en unknown
- 2006-12-07 NO NO20065657A patent/NO20065657L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20070040753A (ko) | 2007-04-17 |
| WO2005110358A2 (de) | 2005-11-24 |
| CN1997349A (zh) | 2007-07-11 |
| JP2007537178A (ja) | 2007-12-20 |
| RU2006140649A (ru) | 2008-05-27 |
| AU2005244409A1 (en) | 2005-11-24 |
| MXPA06012890A (es) | 2007-07-19 |
| WO2005110358A3 (de) | 2007-03-15 |
| DE102004023984A1 (de) | 2005-12-08 |
| TW200536547A (en) | 2005-11-16 |
| CA2566325A1 (en) | 2005-11-24 |
| EP1761242A2 (de) | 2007-03-14 |
| IL179014A0 (en) | 2007-03-08 |
| BRPI0510855A (pt) | 2007-12-26 |
| US20070243217A1 (en) | 2007-10-18 |
| AR048958A1 (es) | 2006-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2444072A3 (en) | Non-mucoadhesive film dosage forms | |
| PE20040134A1 (es) | Forma de dosificacion de una vez al dia de pramipexol | |
| WO2008142572A3 (en) | Controlled release tablet formulation containing magnesium aluminometasilicate | |
| EP2246049A3 (en) | Pharmaceutical composition and dosage forms for administration of hydrophobic drugs | |
| WO2005065069A3 (en) | Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease | |
| NO20090887L (no) | Fremgangsmate for behandling og forebygging av mukositt | |
| CR7654A (es) | Una combinacion de azelatina y esteroides | |
| CY1110495T1 (el) | Χρηση ενος αγωνιστη υποδοχεα nmda για τη θεραπεια εμβοης που προκαλειται απο κοχλιακη διεγερτοτοξικοτητα | |
| JP2006508953A5 (pt) | ||
| JP2009536147A5 (pt) | ||
| NO330947B1 (no) | Anvendelse av farmasoytiske sammensetninger som inneholder okskarbazepin, i fastende tilstand | |
| HRP20120264T1 (hr) | Farmaceutski sastavi neuroaktivnog steroida i njihove uporabe | |
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| JP2014528474A5 (pt) | ||
| WO2006125819A3 (fr) | Forme medicamenteuse orale, microparticulaire, anti-mesusage | |
| EP2216024A3 (en) | Use of Ranolazine for the treatment of cardiovascular diseases | |
| NO20073403L (no) | Anvendelse av atazanavir til forbedring av farmakokinetikken til legemidler metabolisert av UGT1A1 | |
| AR045289A1 (es) | Forma de dosificacion oral de liberacion controlada que comprende 4-(2-di-n-propilaminoetil) - 2(3h)-indolona (ropi-nirol) y uso de dicha forma de dosificacion para la elaboracion de un medicamento | |
| WO2009026473A3 (en) | Stabilized therapeutic compositions and formulations | |
| NO20091644L (no) | Hurtig desintegrerende, lyofiliserte orale formuleringer av en trombinreseptorantagonist | |
| NO20044496L (no) | Torr pulver innhaleringssammensetning | |
| Kollar et al. | Meta-analysis of the efficacy of a single dose of phenylephrine 10 mg compared with placebo in adults with acute nasal congestion due to the common cold | |
| NO20080244L (no) | Doseringsstyring for prasugrel | |
| WO2004034962A3 (en) | Selective cytokine inhibitory drugs for treating myelodysplastic syndrome | |
| WO2007086079A3 (en) | Sustained release dosage form of phenothiazine derivatives containing channelizer |